According to a recent report by Grand View Research, Inc., the global nucleic acid isolation and purification market is projected to reach a value of USD 9.77 billion by the year 2030. This market is expected to grow at a robust compound annual growth rate (CAGR) of 9.61% from 2025 to 2030. The anticipated growth of this market is largely driven by several critical factors, including the rising global incidence of cancer and chronic diseases, as well as the increasing availability of public and private funding for research in biotechnology and life sciences. Governments and private organizations around the world are continuously investing in biomedical research to enhance diagnostics, therapeutic development, and precision healthcare—all of which rely heavily on effective nucleic acid isolation and purification techniques.

In addition to disease prevalence and funding support, significant progress in automation and advanced technology is accelerating the market’s expansion. Automation has drastically improved the speed, reproducibility, and accuracy of nucleic acid extraction processes, making it easier to handle high-throughput workflows in both research and clinical laboratories. The growing global demand for genetically modified organisms (GMOs) and crops—driven by the need for improved agricultural productivity and food security—is also contributing to the rising adoption of nucleic acid purification tools. A notable example is the advancement by HiMedia Laboratories in December 2023, where the company highlighted the effectiveness of magnetic bead-based extraction systems. These systems offer superior efficiency and scalability in nucleic acid isolation and have found applications across multiple end-use industries, including pharmaceuticals, agriculture, and diagnostics.

A major area benefiting from nucleic acid isolation and purification technologies is precision medicine. This field involves tailoring medical treatment to individual genetic profiles, and it continues to expand rapidly, particularly in addressing complex conditions such as cancer, diabetes, rheumatoid arthritis, neurological disorders, and autoimmune diseases. Precision medicine has introduced new approaches to gene manipulation, enabling the development of therapies that target specific genetic abnormalities. For example, various companies are investing in delivery platforms for nucleic acids—such as small interfering RNAs (siRNAs)—which are designed to modulate gene expression and correct mutations linked to numerous health conditions. These platforms aim to treat diseases that were previously considered untreatable by conventional therapies. As researchers strive to develop more effective and personalized treatments, the importance of nucleic acid isolation and purification technologies becomes even more critical in enabling these breakthroughs.

Furthermore, research and development (RD) efforts in human genomics, primarily led by pharmaceutical and biotechnology companies, have significantly advanced the diagnosis and treatment of diseases. Nucleic acid isolation and purification kits and instruments are indispensable in several areas of biomedical research, particularly in the development of new drugs, the identification of therapeutic targets, and gene-editing applications. These technologies serve as foundational tools in genome sequencing, cloning, and functional genomics studies.

Curious about the Nucleic Acid Isolation And Purification Market? Download your FREE sample copy now and get a sneak peek into the latest insights and trends. 

Here are some commonly asked questions related to the Nucleic Acid Isolation And Purification Market, along with answers that provide essential insights.

1. How big is the nucleic acid isolation and purification market?

The global nucleic acid isolation and purification market size was estimated at USD 5.75 billion in 2024 and is expected to reach USD 6.17 billion in 2025.

2. What is the nucleic acid isolation and purification market growth?

The global nucleic acid isolation and purification market is expected to witness a compound annual growth rate of 9.61% from 2025 to 2030 to reach USD 9.77 billion by 2030.

3. Which product accounted for the largest nucleic acid isolation and purification market share?

Kits and reagents accounted for the largest share in 2024 due to the wide availability of robust kits for isolation of DNA or RNA from the given sample contributed to the dominance of this segmen

4. Who are the key companies/players in the nucleic acid isolation and purification market?

Some key players operating in the nucleic acid isolation and purification market include Thermo Fisher Scientific, Inc., QIAGEN, Merck KGaA, Illumina, Inc., Danaher, F. Hoffmann-La Roche Ltd, Agilent Technologies, Bio-Rad Laboratories, Inc., Takara Bio Inc., Promega Corporation

5. What are the factors driving the nucleic acid isolation and purification market?

Expanding pipeline for RNA therapeutics, plummeting sequencing cost, and growing popularity of nucleic acid-based diagnostics are some key driving factors of the nucleic acid isolation purification market.

Order a free sample PDF of the Nucleic Acid Isolation And Purification Market Intelligence Study, published by Grand View Research.